MP
INO icon

McDonald Partners’s Inovio Pharmaceuticals INO Stock Holding History

McDonald Partners’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64 Buy
+58
New +$69 ﹤0.01% 618

Other funds holding INO

MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
MAFA
MJT & Associates Financial Advisory Monteviceo, Minnesota $151M AUM 22.54% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $194M AUM
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

McDonald Partners's INO Position: Q2 2026 in Review

McDonald Partners opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 58 shares worth $64. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings.

22 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • McDonald Partners held 58 shares of Inovio Pharmaceuticals worth $64 as of Q2 2026.
  • Inovio Pharmaceuticals was a new McDonald Partners position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of McDonald Partners's portfolio in Q2 2026, its #618 holding.
  • 22 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.